{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:26:22Z","timestamp":1789647982525,"version":"4.0.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biomaterials.2019.119293","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:55:36Z","timestamp":1561056936000},"page":"119293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis\/painful bladder syndrome"],"prefix":"10.1016","volume":"217","author":[{"given":"M. Martin","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"Schults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Steinhauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Zachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siam","family":"Oottamasathien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2019.119293_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0090-4295(99)80329-X","article-title":"Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis","volume":"49","author":"Elbadawi","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.biomaterials.2019.119293_bib3","article-title":"Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2019.119293_bib4","doi-asserted-by":"crossref","first-page":"143ra100","DOI":"10.1126\/scitranslmed.3003804","article-title":"Continuous intravesical lidocaine treatment for interstitial cystitis\/bladder pain syndrome: safety and efficacy of a new drug delivery device","volume":"4","author":"Nickel","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2019.119293_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","article-title":"Treatment of interstitial cystitis with intravesical heparin","volume":"73","author":"Parsons","year":"1994","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2007.09.067","article-title":"Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin","volume":"71","author":"Welk","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.biomaterials.2019.119293_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","article-title":"Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome","volume":"103","author":"Nickel","year":"2009","journal-title":"BJU Int."},{"key":"10.1016\/j.biomaterials.2019.119293_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1743-6109.2011.02542.x","article-title":"Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis","volume":"9","author":"Parsons","year":"2012","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.biomaterials.2019.119293_bib9","first-page":"543","article-title":"Treatment of painful bladder syndrome\/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients?","volume":"4","author":"Lamarre","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/21681805.2015.1121406","article-title":"Intravesical instillation of onabotulinum toxin A embedded in inert hydrogel in the treatment of idiopathic overactive bladder: a double-blind randomized pilot study","volume":"50","author":"Krhut","year":"2016","journal-title":"Scand. J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation OnabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/alr.21865","article-title":"Prevention of sinonasal inflammation by a synthetic glycosaminoglycan","volume":"7","author":"Pulsipher","year":"2017","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib13","first-page":"e181","article-title":"State of the art in intravesical therapy for lower urinary tract symptoms","volume":"12","author":"Kaufman","year":"2010","journal-title":"Rev. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119293_bib15","first-page":"169","article-title":"Novel targeted bladder drug-delivery systems: a review","volume":"7","author":"Zacch\u00e8","year":"2015","journal-title":"Res. Rep. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib16","doi-asserted-by":"crossref","first-page":"21107","DOI":"10.1021\/acsami.6b00371","article-title":"Temperature-responsive smart nanocarriers for delivery of therapeutic agents: applications and recent advances","volume":"8","author":"Karimi","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2019.119293_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2014.06.016","article-title":"Controlled release from recombinant polymers","volume":"190","author":"Price","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119293_bib18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1517\/17425247.2014.926885","article-title":"The potential of recombinant human elastin-like polypeptides for drug delivery","volume":"11","author":"Ciofani","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2019.119293_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0169-409X(02)00063-7","article-title":"Genetically engineered silk-elastinlike protein polymers for controlled drug delivery","volume":"54","author":"Megeed","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2019.119293_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.polymer.2008.11.047","article-title":"Silk\u2013elastinlike protein polymer hydrogels: influence of monomer sequence on physicochemical properties","volume":"50","author":"Dandu","year":"2009","journal-title":"Polymer"},{"key":"10.1016\/j.biomaterials.2019.119293_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2015.06.022","article-title":"In vivo evaluation of matrix metalloproteinase responsive silk\u2013elastinlike protein polymers for cancer gene therapy","volume":"213","author":"Price","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119293_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/acs.molpharmaceut.6b00325","article-title":"Silk-elastinlike protein polymer liquid chemoembolic for localized release of doxorubicin and sorafenib","volume":"13","author":"Poursaid","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119293_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biomaterials.2015.04.015","article-title":"In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization","volume":"57","author":"Poursaid","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119293_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2014.07.044","article-title":"Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels","volume":"195","author":"Price","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119293_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/bm3013692","article-title":"Synthesis and characterization of a matrix-metalloproteinase responsive silk\u2013elastinlike protein polymer","volume":"14","author":"Gustafson","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2019.119293_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/mp049906s","article-title":"Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization","volume":"2","author":"Haider","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119293_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.02.025","article-title":"Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis","volume":"263","author":"Jensen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119293_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2011.09.037","article-title":"Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery","volume":"427","author":"Price","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119293_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0883911507085278","article-title":"Characterization of structurally related adenovirus-laden silk-elastinlike hydrogels","volume":"23","author":"Dandu","year":"2008","journal-title":"J. Bioact. Compat Polym."},{"key":"10.1016\/j.biomaterials.2019.119293_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3109\/03639041003680826","article-title":"PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate","volume":"36","author":"Gao","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119293_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.07.026","article-title":"Injectable block copolymer hydrogels for sustained release of a PEGylated drug","volume":"348","author":"Yu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119293_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00390","article-title":"Thermogelling properties of purified poloxamer 407","volume":"3","author":"Fakhari","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.biomaterials.2019.119293_bib33","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council National Council","year":"2011"},{"key":"10.1016\/j.biomaterials.2019.119293_bib34","series-title":"The Antimicrobial Peptide Cathelicidin Protects the Urinary Tract against Invasive Bacterial Infection","first-page":"12","author":"Chromek","year":"2006"},{"key":"10.1016\/j.biomaterials.2019.119293_bib35","first-page":"10","article-title":"Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model","volume":"5","author":"Jia","year":"2017","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib36","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.juro.2013.01.002","article-title":"Physiological relevance of LL-37 induced bladder inflammation and mast cells","volume":"190","author":"Oottamasathien","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib37","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2011.03.099","article-title":"A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides","volume":"186","author":"Oottamasathien","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2490-9-16","article-title":"Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis","volume":"9","author":"Rudick","year":"2009","journal-title":"BMC Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1533-2500.2009.00293.x","article-title":"Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results","volume":"9","author":"Cappelleri","year":"2009","journal-title":"Pain Pract."},{"key":"10.1016\/j.biomaterials.2019.119293_bib40","doi-asserted-by":"crossref","first-page":"F1296","DOI":"10.1152\/ajprenal.00074.2014","article-title":"Spontaneous voiding by mice reveals strain-specific lower urinary tract function to be a quantitative genetic trait","volume":"306","author":"Yu","year":"2014","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib41","first-page":"1143","volume":"175","author":"Erickson","year":"2006","journal-title":"Molecular Size Affects Urine Excretion of Pentosan Polysulfate"},{"key":"10.1016\/j.biomaterials.2019.119293_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s002280050577","article-title":"The oral bioavailability of pentosan polysulphate sodium in healthy volunteers","volume":"54","author":"Faaij","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib43","series-title":"ELMIRON \u00ae-100 MG [prescribing Information]","year":"2018"},{"key":"10.1016\/j.biomaterials.2019.119293_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","article-title":"Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial","volume":"179","author":"Davis","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib45","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.5489\/cuaj.3786","article-title":"CUA guideline: diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Cox","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.biomaterials.2019.119293_bib46","article-title":"Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2019.119293_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157310","article-title":"A modified glycosaminoglycan, GM-0111, inhibits molecular signaling involved in periodontitis","volume":"11","author":"Savage","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2019.119293_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cyto.2018.05.012","article-title":"IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model","volume":"110","author":"Martin Jensen","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.biomaterials.2019.119293_bib49","doi-asserted-by":"crossref","first-page":"E1005","DOI":"10.3390\/ma9121005","article-title":"Floating hydrogel with self-generating micro-bubbles for intravesical instillation","volume":"9","author":"Lin","year":"2016","journal-title":"Materials"},{"key":"10.1016\/j.biomaterials.2019.119293_bib50","first-page":"272","article-title":"Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: safety and feasibility","volume":"35","author":"Donin","year":"2017","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.biomaterials.2019.119293_bib51","series-title":"US20130046275A1 Material and Method for Treating Internal Cavities","author":"Holzer","year":"2013"},{"key":"10.1016\/j.biomaterials.2019.119293_bib52","series-title":"US 2011\/0319442 A1 Pharmaceutical Compositions Comprising Imidazoquinolin(amines) and Dervatives Thereof Suitable for Local Administration","author":"Leoni","year":"2011"},{"key":"10.1016\/j.biomaterials.2019.119293_bib53","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e16089","article-title":"Thermo reversible hydrogel based delivery of mitomycin C for treatment of upper tract urothelial carcinoma (UTUC)","volume":"35","author":"Lin","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib54","doi-asserted-by":"crossref","first-page":"F1274","DOI":"10.1152\/ajprenal.00318.2017","article-title":"Evaluating the voiding spot assay in mice: a simple method with complex environmental interactions","volume":"313","author":"Chen","year":"2017","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib55","first-page":"69","article-title":"Postsurgical food and water consumption, fecal corticosterone metabolites, and behavior assessment as noninvasive measures of pain in vasectomized BALB\/c mice","volume":"51","author":"Jacobsen","year":"2012","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.biomaterials.2019.119293_bib56","first-page":"572","article-title":"Intravesical liposome drug delivery and IC\/BPS, Transl","volume":"4","author":"Janicki","year":"2015","journal-title":"Androl. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","article-title":"Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/iju.13317","article-title":"Intravesical liposome therapy for interstitial cystitis","volume":"24","author":"Tyagi","year":"2017","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/toxins8030081","article-title":"Potential effect of liposomes and liposome-encapsulated botulinum toxin and tacrolimus in the treatment of bladder dysfunction","volume":"8","author":"Janicki","year":"2016","journal-title":"Toxins"},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2019.119293_bib60","first-page":"S27","article-title":"Future trends in the treatment of urinary incontinence","volume":"3","author":"Chancellor","year":"2001","journal-title":"Rev. Urol."},{"key":"10.1016\/j.biomaterials.2019.119293_bib61","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00192-012-2003-9","article-title":"Pain in interstitial cystitis\/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes?","volume":"24","author":"Killinger","year":"2013","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.biomaterials.2019.119293_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0304-3959(01)00275-5","article-title":"A new model of visceral pain and referred hyperalgesia in the mouse","volume":"92","author":"Laird","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.biomaterials.2019.119293_bib63","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5213\/inj.1835062.531","article-title":"Animal modelling of interstitial cystitis\/bladder pain syndrome","volume":"22","author":"Birder","year":"2018","journal-title":"Int. Neurourol. J."},{"key":"10.1016\/j.biomaterials.2019.119293_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11255-014-0808-9","article-title":"Pathophysiology and animal modeling of underactive bladder","volume":"46","author":"Tyagi","year":"2014","journal-title":"Int. Urol. Nephrol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219303928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219303928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:47:43Z","timestamp":1758905263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219303928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":64,"alternative-id":["S0142961219303928"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119293","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736483625.793564408","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis\/painful bladder syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119293"}}